Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119395) titled 'A study on the application of Remimazolam in elderly patients undergoing laparoscopic hepatectomy' on Feb. 26.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Affiliated Hospital of Chengde Medical University
Condition:
Liver disease
Intervention:
Remimazolam group (Group R):Remimazolam induction (0.15 mg/kg) and maintenance (0.5 - 1 mg/kg/h)
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-11-10
Target Sample Size: Remimazolam group (Group R):50;Propofol group (Group P):50;
Countries of Recruitment:
China
To know more, visit https://www.chict...